News & Events about Evolus Inc.
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its first quarter 2023 financial results and provide a business update on Tuesday, May 9, 2023, after the U.S. financial...
Business Wire
3 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida. Event: Barclays...
Business Wire
3 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, has commenced the commercial launch of Nuceiva (botulinum toxin type A) in Germany and Austria, and is now available for direct order and delivery to customers...
Ticker Report
3 months ago
Evolus, Inc. (NASDAQ:EOLS Get Rating) major shareholder Alphaeon 1 Llc sold 1,850,000 shares of Evolus stock in a transaction that occurred on Friday, February 17th. The shares were sold at an average price of $8.40, for a total transaction of $15,540,000.00. Following the completion of the ...
Business Wire
3 months ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its fourth quarter and year end 2022 financial results and provide a business update on Wednesday, March 8, 2023, after the...